NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Ysios Capital

Ysios Capital

Overview

Ysios Capital is a life sciences venture capital firm that provides private equity financing to early- and mid-stage, highly innovative biotech companies developing novel therapies for indications with high unmet medical needs.

Year Founded

2008

Portfolio Companies

27

Investments

Ysios Capital investments
CompanyDateStageLead
Ona TherapeuticsJun 2026Series BCo-investor
AdcendoApr 2026Series CCo-investor
SpliceBioJun 2025Series BCo-investor
ReproNovoMay 2025Series ACo-investor
Neurona TherapeuticsApr 2025VC RoundCo-investor

Key People

Julia Salaverria

Managing Partner

Karen Wagner

General Partner

Pamela Klein

Venture Partner

Arturo Urrios

Partner

Guillem Laporta

Partner

Jordi Xiol

Partner

Thomas Harth

Partner

Cristina Garmendia Mendizábal

Founding Partner and Member of the Board

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersBarcelona
Year Founded2008

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.